T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKatie Ewer, Megan Baker, Amy Flaxman et al.|Nature Medicine|2020Cited by 643
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in childrenHamtandi Magloire Natama, Angela M. Minassian, Jo Salkeld et al.|The Lancet Infectious Diseases|2024Cited by 39
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in childrenHamtandi Magloire Natama, Angela M. Minassian, Jo Salkeld et al.|medRxiv|2024Cited by 1